MetaADEDB: ADE

MetaADEDB 2.0 @ LMMD

Sarcoma, Experimental

(UMLS:C0036216)

Definition:: Experimentally induced neoplasms of CONNECTIVE TISSUE in animals to provide a model for studying human SARCOMA.
UMLS ID:: C0036216
MeSH ID:: D012513

Classification 1:

Name:

Neoplasms
MeSH Tree Number(s):: C04.557.450.795.830|C04.619.857

Classification 2:

Name:

Investigative Techniques
MeSH Tree Number(s):: E05.598.500.496.968

Synonym(s)

Sarcoma, Experimental

Associated Drug(s)

	Name	Reference(s)	Data Source
1	1,3-dinitropyrene	6722977	CTD
2	1,6-dinitropyrene	3971343	CTD
3	1,8-dinitropyrene	3971343 6722977	CTD
4	3,3-difluorochlorambucil	3698174	CTD
5	Azacitidine	2408741	CTD
6	Carmustine	7107385	CTD
7	Chlorambucil	3698174 7107385	CTD
8	Cyclophosphamide	7107385 11245434	CTD
9	Lomustine	6831472 7107385 7150475	CTD
10	Medroxyprogesterone Acetate	3522997	CTD
11	Melphalan	3698174	CTD
12	Metronidazole	7150475	CTD
13	Misonidazole	View details 3698174 6831472 7107385 7150475	CTD
14	Nimorazole	7150475	CTD
15	Nitrofurantoin	7107385	CTD
16	Nitrofurazone	7150475	CTD
17	Phenoxybenzamine	6123488	CTD
18	Proadifen	7107385 7150475	CTD
19	Propranolol	6123488	CTD
20	Ro 07-1902	7107385 7150475	CTD
21	Semustine	7107385	CTD
22	benzonidazole	7107385 7150475	CTD
23	mangiferin	8957579	CTD
24	tomizine	421896	CTD

Similar ADE(s)

	Name	Semantic Similarity
1	Leukemia, Experimental	41.3%
2	Mammary Neoplasms, Experimental	38%
3	Carcinoma 256, Walker	37.1%
4	Chondrosarcoma	35.5%
5	leiomyosarcoma	35.5%
6	liposarcoma	35.5%
7	synovial sarcoma	35.5%
8	Clear Cell Sarcoma of Soft Tissue	35.5%
9	Alveolar Soft Part Sarcoma	35.5%
10	Melanoma, Experimental	35.3%
11	Carcinosarcoma	33.1%
12	Hemangiosarcoma	33.1%
13	lymphangiosarcoma	33.1%
14	Fibrosarcoma	32.8%
15	Osteosarcoma	32.8%
16	Malignant Fibrous Histiocytoma	31.4%
17	Sarcoma, Myeloid	30.3%
18	Phyllodes Tumor	28.9%
19	Desmoplastic Small Round Cell Tumor	28.9%
20	Liver Neoplasms, Experimental	27.5%
21	Rhabdomyosarcoma	27.5%
22	Carcinoma, Ehrlich Tumor	26.8%
23	Carcinoma, Lewis Lung	26.8%
24	Dermatofibrosarcoma	26.1%
25	Dermatofibrosarcoma Protuberans	26.1%
26	Angiomyolipoma	25%
27	Alveolar rhabdomyosarcoma	23.5%
28	Leukemia L1210	21.2%
29	Leukemia P388	21.2%
30	Neoplasms, Neuroepithelial	20.3%
31	Gliomatosis cerebri	20.3%
32	Neuroectodermal Tumors	20%
33	Neurofibrosarcoma	19.8%
34	Giant Cell Tumor of Bone	19.6%
35	Endometrial Stromal Sarcoma	19.5%
36	leukemia	19.5%
37	Neoplasms, Germ Cell and Embryonal	19.5%
38	Neoplasms, Glandular and Epithelial	19.5%
39	Germ Cell Cancer	19.5%
40	Hamartoma	18.4%
41	Neoplasms, Hormone-Dependent	18.4%
42	Neoplasms, Multiple Primary	18.4%
43	Paraneoplastic Syndromes	18.4%
44	Precancerous Conditions	18.4%
45	Neoplasms, Second Primary	18.4%
46	melanoma	18%
47	Medulloblastoma	17.9%
48	Meningioma	16.9%
49	Dermoid Cyst	16.1%
50	Adenoma, Acidophil	15.8%
51	Ganglioneuroma	15.8%
52	Glioma	15.8%
53	Malignant Glioma	15.8%
54	Trophoblastic Neoplasms	15.7%
55	Adenofibroma	15.7%
56	Fibroadenoma	15.7%
57	Lipoma	15.7%
58	Myoma	15.7%
59	Myxoma	15.7%
60	Angiolipoma	15.7%
61	Myelolipoma	15.7%
62	Neoplasms, Bone Tissue	15.7%
63	Neoplasms, Fibrous Tissue	15.7%
64	Smooth Muscle Tumor	15.7%
65	Chondroma	15.7%
66	Enchondroma	15.7%
67	Histiocytic Disorders, Malignant	15.5%
68	Multiple Endocrine Neoplasia	15%
69	Cyst	14.8%
70	Neoplastic Processes	14.8%
71	Neoplastic Syndromes, Hereditary	14.8%
72	Pregnancy Complications, Neoplastic	14.8%
73	Carcinoid Tumor	14.6%
74	Neurilemmoma	14.6%
75	Hutchinson's Melanotic Freckle	14.6%
76	Melanoma, Amelanotic	14.6%
77	Basal cell carcinoma	14.5%
78	Carcinoma, Papillary	14.5%
79	Squamous cell carcinoma	14.5%
80	Craniopharyngioma	14.5%
81	Cystadenoma	14.5%
82	Mesothelioma	14.5%
83	Neuroectodermal Tumor, Melanotic	14.5%
84	Neuroendocrine Tumors	14.5%
85	Carcinoma, Basal Cell	14.5%
86	Leukemia, Plasma Cell	14.3%
87	Composite Lymphoma	14.2%
88	Lymphangioleiomyomatosis	14%
89	Liver Cirrhosis, Experimental	14%
90	Arthritis, Experimental	14%
91	Choriocarcinoma	13.6%
92	Carcinoma, Lobular	13.6%
93	Leukemia, Radiation-Induced	13.5%
94	Astrocytoma	13.5%
95	Ependymoma	13.5%
96	oligodendroglioma	13.5%
97	Ganglioglioma	13.5%
98	gliosarcoma	13.5%
99	Anaplastic astrocytoma	13.5%
100	Anaplastic Oligodendroglioma	13.5%
101	Acanthoma	13.2%
102	Cystadenocarcinoma	13.1%
103	Mucoepidermoid Carcinoma	13.1%
104	Malignant Carcinoid Syndrome	13%
105	Lymphoma	12.9%
106	Adenoma	12.5%
107	Ameloblastoma	12.5%
108	Angiokeratoma	12.5%
109	Carcinoma	12.5%
110	Chordoma	12.5%
111	Hemangioma	12.5%
112	hemangiopericytoma	12.5%
113	Lymphangioma	12.5%
114	Mesenchymoma	12.5%
115	Nevus	12.5%
116	Teratoma	12.5%
117	Hepatoblastoma	12.5%
118	Mixed Tumor, Mullerian	12.5%
119	Germinoma	12.5%
120	Teratocarcinoma	12.5%
121	Angiofibroma	12.5%
122	Paraneoplastic Encephalomyelitis	12.5%
123	Epithelioma	12.5%
124	Glioblastoma	12.4%
125	Neuroblastoma	12.4%
126	Glioblastoma Multiforme	12.4%
127	fibroma	12.3%
128	Fibromatosis	12.3%
129	Osteoblastoma	12.3%
130	Osteoma	12.3%
131	Rhabdomyoma	12.3%
132	Chondromatosis	12.3%
133	Thymoma	12.2%
134	Neoplasms, Radiation-Induced	12.1%
135	Retinoblastoma	11.9%
136	Ganglioneuroblastoma	11.8%
137	Bowen's Disease	11.8%
138	Paraganglioma	11.8%
139	Diabetes Mellitus, Experimental	11.7%
140	Abdominal Neoplasms	11%
141	Erythroplasia	11%
142	Follicular cyst	11%
143	Head and Neck Neoplasms	11%
144	Mucocele	11%
145	Pilonidal Cyst	11%
146	Soft Tissue Neoplasms	11%
147	Thoracic Neoplasms	11%
148	Thyroglossal Cyst	11%
149	Synovial Cyst	11%
150	Aberrant Crypt Foci	11%
151	Tuberous Sclerosis	11%
152	Fibromatosis, Aggressive	10.7%
153	Fibromatosis, Abdominal	10.7%
154	Mastocytosis	10.6%
155	Carcinoid Heart Disease	10.5%
156	Gastrointestinal Stromal Tumors	10.5%
157	Pheochromocytoma	10.4%
158	Multiple Endocrine Neoplasia Type 1	10.3%
159	Lymphomatoid Granulomatosis	10.3%
160	Nephroblastoma	10.2%
161	Carcinoma, Pancreatic Ductal	10.2%
162	Basal Cell Nevus Syndrome	10.2%
163	Acoustic Neuroma	10.1%
164	Plasmacytoma	10%
165	Malignant histiocytosis	9.9%
166	Histiocytic sarcoma	9.9%
167	Mastocytoma	9.9%
168	Mastocytosis, Systemic	9.8%
169	Digestive System Neoplasms	9.2%
170	Endocrine Gland Neoplasms	9.2%
171	Eye Neoplasms	9.2%
172	Nervous System Neoplasms	9.2%
173	Adenocarcinoma	9.1%
174	Carcinoma in Situ	9.1%
175	Carcinoma, Transitional Cell	9.1%
176	Dysgerminoma	9.1%
177	Hemangioendothelioma	9.1%
178	Neuroma	9.1%
179	Papilloma	9.1%
180	Pseudomyxoma Peritonei	9.1%
181	Seminoma	9.1%
182	Papillomatosis	9.1%
183	Adenomatosis, Pulmonary	9.1%
184	Adenomatous Polyps	9.1%
185	Carcinoma, Large Cell	9.1%
186	Carcinoma, Small Cell	9.1%
187	Optic Nerve Glioma	9.1%
188	Vipoma	9%
189	Bone neoplasms	8.9%
190	Leukoplakia	8.9%
191	Lymphocele	8.9%
192	Pancreatic Cyst	8.9%
193	Skin Neoplasms	8.9%
194	Hematologic Neoplasms	8.9%
195	Barrett Esophagus	8.8%
196	Breast Cyst	8.8%
197	Actinic keratosis	8.8%
198	Mediastinal Cyst	8.8%
199	Neoplasm Invasiveness	8.8%
200	Neoplasm Metastasis	8.8%
201	Neoplasm Recurrence, Local	8.8%
202	Parovarian Cyst	8.8%
203	Pericardial Cyst	8.8%
204	Splenic Neoplasms	8.8%
205	Thymic Cyst	8.8%
206	Carcinogenesis	8.8%
207	Myxoid cyst	8.8%
208	Metastasis	8.8%
209	Parathyroid Neoplasms	8.7%
210	Peritoneal Neoplasms	8.7%
211	Thyroid Neoplasm	8.7%
212	Thyroid carcinoma	8.7%
213	Hydatidiform Mole	8.7%
214	Radiation Injuries, Experimental	8.7%
215	Hepatocellular Adenoma	8.5%
216	Hodgkin Disease	8.2%
217	Lymphoma, Non-Hodgkin	8.2%
218	Device Failure	7.9%
219	Tracheal Neoplasms	7.7%
220	Pancreatic Neoplasm	7.7%
221	Mesoblastic Nephroma	7.6%
222	Leukoplakia, Oral	7.6%
223	insulinoma	7.6%
224	Paraneoplastic Cerebellar Degeneration	7.5%
225	Retroperitoneal Neoplasms	7.5%
226	Adenomatous Polyposis Coli	7.5%
227	Adenoid Cystic Carcinoma	7.4%
228	Adenocarcinoma, Clear Cell	7.4%
229	Cholangiocarcinoma	7.4%
230	Cervical Intraepithelial Neoplasia	7.4%
231	Hemangioblastoma	7.4%
232	Lymphoma, Extranodal NK-T-Cell	7.4%
233	Prolactinoma	7.4%
234	Growth Hormone-Secreting Pituitary Adenoma	7.4%
235	Corpus Luteum Cyst	7.2%
236	Ovarian Cysts	7.2%
237	Leukemia, Myelomonocytic, Chronic	7.2%
238	Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative	7.2%
239	Dupuytren Contracture	7.2%
240	Gastrinoma	7.2%
241	Glucagonoma	7.2%
242	Urticaria Pigmentosa	7.1%
243	Primary amyloidosis	7.1%
244	Electrophoresis	6.8%
245	Esophageal Neoplasms	6.6%
246	Leydig Cell Tumor	6.6%
247	Thyroid Nodule	6.6%
248	Limbic Encephalitis	6.6%
249	Neuritis, Autoimmune, Experimental	6.6%
250	Klatskin Tumor	6.6%
251	Intubation	6.5%
252	granulosa cell tumor	6.5%
253	Carcinoma, Ovarian Epithelial	6.5%
254	Choledochal Cyst	6.3%
255	Cytogenetic Analysis	6.3%
256	Neoplasms, Experimental	6.2%
257	Peutz-Jeghers Syndrome	6.2%
258	Sturge-Weber Syndrome	6.1%
259	Adrenocortical carcinoma	6.1%
260	Mouth Neoplasms	6.1%
261	Central Nervous System Neoplasms	6.1%
262	Vascular Neoplasms	6.1%
263	Thymus Neoplasms	6.1%
264	Hemangioma, Cavernous	6%
265	Leukemia, T-Cell	6%
266	Leukemia, B-Cell	6%
267	Genital Neoplasms, Female	6%
268	Pancreatic Pseudocyst	6%
269	neurofibroma	6%
270	Lymphoma, Follicular	6%
271	T-Cell Lymphoma	6%
272	Mantle cell lymphoma	6%
273	Lymphatic Metastasis	6%
274	Neoplasms, Unknown Primary	6%
275	Leukemic Infiltration	6%
276	Breast Neoplasms, Male	6%
277	Neoplasm Micrometastasis	6%
278	Triple Negative Breast Neoplasms	6%
279	Lambert-Eaton Myasthenic Syndrome	5.9%
280	Testicular Neoplasms	5.9%
281	Leukemia, Myeloid, Chronic-Phase	5.9%
282	Sarcoma, Experimental	5.6%
283	Waldenstrom Macroglobulinemia	5.5%
284	Multiple Myeloma	5.5%
285	Denys-Drash Syndrome	5.5%
286	Renal Cell Carcinoma	5.4%
287	Papillary Renal Cell Carcinoma	5.4%
288	Nasopharyngeal carcinoma	5.4%
289	Opsoclonus-Myoclonus Syndrome	5.3%
290	Autopsy	5.2%
291	Carcinoma, Endometrioid	5.2%
292	Microscopy	5.2%
293	Adrenal Gland Neoplasms	5.1%
294	Gastrointestinal Neoplasms	5.1%
295	Genital Neoplasms, Male	5.1%
296	Liver neoplasms	5.1%
297	Uveal Neoplasms	5.1%
298	Myasthenia Gravis, Autoimmune, Experimental	5.1%
299	Urologic Neoplasms	5.1%
300	Sebaceous Gland Neoplasms	5%
301	Spinal Neoplasms	5%
302	Bone Marrow Neoplasms	5%
303	Sarcoma	5%
304	Sarcoma 180	5%
305	Polycystic Ovary Syndrome	4.9%
306	Precursor B-Cell Lymphoblastic Leukemia-Lymphoma	4.9%
307	Leukemia, Large Granular Lymphocytic	4.9%
308	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	4.9%
309	Lymphoma, T-Cell, Cutaneous	4.9%
310	Lymphoma, AIDS-Related	4.9%
311	Enteropathy-Associated T-Cell Lymphoma	4.9%
312	Primary Effusion Lymphoma	4.9%
313	Myelitis, Transverse	4.8%
314	Nose Neoplasms	4.7%
315	Palatal Neoplasms	4.7%
316	Meningeal Neoplasms	4.6%
317	Mycosis Fungoides	4.3%
318	Lymphomatoid Papulosis	4.3%
319	Plasmablastic lymphoma	4.3%
320	Pituitary Adenoma	4.3%
321	Pituitary Neoplasms	4.3%
322	Gastric Lavage	4.2%
323	Peritoneal lavage	4.2%
324	Bronchoalveolar Lavage	4.2%
325	Xeroderma Pigmentosum	4%
326	Ear Neoplasms	4%
327	Eyelid Neoplasms	4%
328	Lung Neoplasms	4%
329	Pleural Neoplasms	4%
330	Meningeal Carcinomatosis	3.9%
331	Cell Transformation, Viral	3.9%
332	Brain Neoplasms	3.9%
333	Salivary Gland Neoplasms	3.9%
334	Spinal Cord Neoplasms	3.9%
335	Tongue Neoplasms	3.9%
336	Uterine Neoplasms	3.8%
337	Vaginal Neoplasms	3.8%
338	Vulvar Neoplasms	3.8%
339	Uterine Cancer	3.8%
340	Fallopian Tube Neoplasms	3.8%
341	ovarian neoplasm	3.7%
342	Burkitt Lymphoma	3.7%
343	Pharyngeal Neoplasms	3.4%
344	Prosthesis Failure	3.4%
345	Immunosuppression	3.4%
346	Central Nervous System Cysts	3.3%
347	Bronchial Neoplasms	3.3%
348	Bile Duct Neoplasms	3.3%
349	gallbladder neoplasm	3.3%
350	Intestinal Neoplasms	3.3%
351	Penile Neoplasms	3.3%
352	Prostatic Neoplasms	3.3%
353	Stomach Neoplasms	3.3%
354	Multiple Pulmonary Nodules	3.3%
355	Polycythemia Vera	3.3%
356	Supratentorial Neoplasms	3.3%
357	Sezary Syndrome	3.3%
358	Endometrial Neoplasms	3.3%
359	Laryngeal neoplasm	3%
360	Brain Stem Neoplasms	3%
361	Zollinger-Ellison syndrome	3%
362	Glasgow coma scale	2.9%
363	Bladder Neoplasm	2.9%
364	Kidney Neoplasm	2.9%
365	Ureteral Neoplasms	2.9%
366	Urethral Neoplasms	2.9%
367	Hypopharyngeal Neoplasms	2.8%
368	Pleural Effusion, Malignant	2.8%
369	Hypopharyngeal Cancer	2.8%
370	Choroid Plexus Papilloma	2.8%
371	Parotid Neoplasms	2.8%
372	Prostatic Neoplasms, Castration-Resistant	2.8%
373	Nelson Syndrome	2.8%
374	Biopsy	2.7%
375	Tonsillar Neoplasms	2.6%
376	Cerebellar Neoplasms	2.5%
377	Polymerase Chain Reaction	2.5%
378	Cecal Neoplasms	2.4%
379	Duodenal Neoplasms	2.4%
380	Angioplasty	2.4%
381	Amniocentesis	2.3%
382	Radicular Cyst	2.2%
383	Appendiceal Neoplasms	2.2%
384	Colonic Neoplasms	2.2%
385	Rectal Neoplasms	2.2%
386	Nasopharyngeal Neoplasms	2.2%
387	Tuberculin Test	2.2%
388	Colorectal Neoplasms	2.2%
389	Ovulation Induction	2%
390	Paranasal Sinus Neoplasms	2%
391	Blood culture	2%
392	Immunoglobulin Therapy	2%
393	Anus Neoplasms	1.9%
394	Sigmoid Neoplasms	1.9%
395	Maxillary Sinus Neoplasms	1.8%
396	Leukapheresis	1.4%
397	Atherectomy	1.4%
398	Body mass index	1.4%
399	Paracentesis	1.1%
400	PROTHROMBIN TIME	1.1%
401	Glucose tolerance test	1.1%
402	Superovulation	1.1%
403	Clot retraction	1.1%
404	venipuncture	1%
405	Body Height	0.9%
406	Body Weight	0.8%
407	Birth Weight	0.6%
408	Fetal Weight	0.5%

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234